Breast Cancer, Adjacent And Adjacent Normal Tissue Array, 66 Cases/72 Cores|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:172888

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Breast Cancer, Adjacent And Adjacent Normal Tissue Array, 66 Cases/72 Cores)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2024年06月01日 08時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Human Breast cancer, adjacent and ajdacent normal tissue array, 66 cases/72 cores
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2024年06月01日 08時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Human Breast cancer, adjacent and ajdacent normal tissue array, 66 cases/72 cores

文献数: 0

説明文
法規制等
保存条件 4℃ 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド/組織アレイの仕様変更につきまして

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Breast carcinoma, adjacent and adjacent normal tissue microarray, containing 24 cases of each invasive ductal carcinoma, adjacent tissue and adjacent normal tissue, single core per case
Cores: 72
組織アレイ
Cases: 66
Layout: 9 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Quality Control: Anti-Actin confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Type †
A1 1 F 43 Breast Cancer adjacent normal breast tissue (adenosis) NAT
A2 2 F 45 Breast Invasive ductal carcinoma 2 Malignant
A3 3 F 43 Breast Cancer adjacent breast tissue (adenosis) AT
A4 4 F 44 Breast Cancer adjacent normal breast tissue NAT
A5 5 F 44 Breast Invasive ductal carcinoma 2 Malignant
A6 6 F 39 Breast Cancer adjacent breast tissue (adenosis) AT
A7 7 F 42 Breast Cancer adjacent normal breast tissue (adenosis) NAT
A8 8 F 40 Breast Invasive ductal carcinoma 2 Malignant
A9 9 F 40 Breast Cancer adjacent breast tissue (adenosis) AT
B1 10 F 42 Breast Cancer adjacent normal breast tissue (sparse) NAT
B2 11 F 42 Breast Invasive ductal carcinoma 2 Malignant
B3 12 F 23 Breast Cancer adjacent breast tissue (sparse) AT
B4 13 F 49 Breast Cancer adjacent normal breast tissue (fibrofatty tissue) NAT
B5 14 F 51 Breast Invasive ductal carcinoma 1–2 Malignant
B6 15 F 49 Breast Cancer adjacent breast tissue (sparse) AT
B7 16 F 38 Breast Cancer adjacent normal breast tissue NAT
B8 17 F 69 Breast Invasive ductal carcinoma 2 Malignant
B9 18 F 40 Breast Cancer adjacent breast tissue (adenosis) AT
C1 19 F 39 Breast Cancer adjacent normal breast tissue (adenosis) NAT
C2 20 F 59 Breast Invasive ductal carcinoma 2 Malignant
C3 21 F 39 Breast Cancer adjacent breast tissue (adenosis) AT
C4 22 F 43 Breast Cancer adjacent normal breast tissue NAT
C5 23 F 48 Breast Invasive ductal carcinoma 2 Malignant
C6 24 F 36 Breast Cancer adjacent breast tissue AT
C7 25 F 50 Breast Cancer adjacent normal breast tissue NAT
C8 26 F 60 Breast Invasive ductal carcinoma 2 Malignant
C9 27 F 62 Breast Cancer adjacent breast tissue (fibrofatty tissue) AT
D1 28 F 35 Breast Cancer adjacent normal breast tissue (adenosis) NAT
D2 29 F 58 Breast Invasive ductal carcinoma (sparse) 2 Malignant
D3 30 F 53 Breast Cancer adjacent breast tissue (fibrofatty tissue) AT
D4 31 F 43 Breast Cancer adjacent normal breast tissue (fibrofatty tissue) NAT
D5 32 F 68 Breast Invasive ductal carcinoma 1–2 Malignant
D6 33 F 30 Breast Cancer adjacent breast tissue (fibrofatty tissue) AT
D7 34 F 50 Breast Cancer adjacent normal breast tissue NAT
D8 35 F 38 Breast Invasive ductal carcinoma 2 Malignant
D9 36 F 36 Breast Cancer adjacent breast tissue (fibrofatty tissue) AT
E1 37 F 45 Breast Cancer adjacent normal breast tissue (adenosis) NAT
E2 38 F 61 Breast Invasive ductal carcinoma (sparse) with necrosis 2 Malignant
E3 39 F 40 Breast Cancer adjacent breast tissue AT
E4 40 F 35 Breast Cancer adjacent normal breast tissue (fibrofatty tissue) NAT
E5 41 F 47 Breast Invasive ductal carcinoma 2 Malignant
E6 42 F 32 Breast Cancer adjacent breast tissue (fibrofatty tissue) AT
E7 43 F 35 Breast Cancer adjacent normal breast tissue NAT
E8 44 F 50 Breast Invasive ductal carcinoma 2 Malignant
E9 45 F 50 Breast Cancer adjacent breast tissue (adenosis) AT
F1 46 F 40 Breast Cancer adjacent normal breast tissue (adenosis) NAT
F2 47 F 65 Breast Invasive ductal carcinoma 2 Malignant
F3 48 F 45 Breast Cancer adjacent breast tissue (fibrofatty tissue) AT
F4 49 F 38 Breast Cancer adjacent normal breast tissue NAT
F5 50 F 53 Breast Invasive ductal carcinoma 2 Malignant
F6 51 F 31 Breast Cancer adjacent breast tissue (ductal epithelium hyperplasia) AT
F7 52 F 48 Breast Cancer adjacent normal breast tissue (adenosis) NAT
F8 53 F 60 Breast Invasive ductal carcinoma (sparse) 2 Malignant
F9 54 F 39 Breast Cancer adjacent breast tissue (adenosis) AT
G1 55 F 37 Breast Cancer adjacent normal breast tissue (adenosis) NAT
G2 56 F 85 Breast Invasive ductal carcinoma 2 Malignant
G3 57 F 35 Breast Cancer adjacent breast tissue AT
G4 58 F 57 Breast Cancer adjacent normal breast tissue NAT
G5 59 F 46 Breast Invasive ductal carcinoma 2 Malignant
G6 60 F 38 Breast Cancer adjacent breast tissue AT
G7 61 F 46 Breast Cancer adjacent normal breast tissue (fibrofatty tissue) NAT
G8 62 F 49 Breast Invasive ductal carcinoma 2 Malignant
G9 63 F 40 Breast Cancer adjacent breast tissue (adenosis) AT
H1 64 F 37 Breast Cancer adjacent normal breast tissue (fibrofatty tissue) NAT
H2 65 F 48 Breast Invasive ductal carcinoma (sparse) 2 Malignant
H3 66 F 49 Breast Cancer adjacent breast tissue AT
H4 67 F 43 Breast Cancer adjacent normal breast tissue NAT
H5 68 F 38 Breast Invasive ductal carcinoma 2 Malignant
H6 69 F 41 Breast Cancer adjacent breast tissue AT
H7 70 F 38 Breast Cancer adjacent normal breast tissue NAT
H8 71 F 53 Breast Invasive ductal carcinoma 2 Malignant
H9 72 F 47 Breast Cancer adjacent breast tissue AT
M 58 Skin Malignant melanoma (tissue marker) Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。